Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
236,833,431
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
32,462,778
-
Shares change
-
-1,127,461
-
Total reported value, excl. options
-
$129,848,396
-
Value change
-
-$5,342,106
-
Put/Call ratio
-
291%
-
Number of buys
-
47
-
Number of sells
-
-25
-
Price
-
$4.00
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2019
88 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2019.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,462,778 shares
of 236,833,431 outstanding shares and own 14% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (11,521,102 shares), Consonance Capital Management LP (5,166,961 shares), BlackRock Inc. (3,971,107 shares), VANGUARD GROUP INC (2,312,539 shares), Schonfeld Strategic Advisors LLC (1,240,793 shares), STATE STREET CORP (843,366 shares), GEODE CAPITAL MANAGEMENT, LLC (716,608 shares), 683 Capital Management, LLC (700,000 shares), NORTHERN TRUST CORP (648,584 shares), and MORGENS WATERFALL VINTIADIS & CO INC (600,000 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.